Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer.

× No keyword cloud information.

24 in total

1. Endocrine resistant breast cancer cells with loss of ERα expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage.

Authors: Shiyi Yu; Xue Gong; Zhifang Ma; Meng Zhang; Ling Huang; Jun Zhang; Shuang Zhao; Tao Zhu; Zhenghong Yu; Liming Chen
Journal: Cell Oncol (Dordr) Date: 2019-11-07 Impact factor: 6.730

2. Role of SUMOylation in full antiestrogenicity.

Authors: Khalid Hilmi; Nader Hussein; Rodrigo Mendoza-Sanchez; Mohamed El-Ezzy; Houssam Ismail; Chantal Durette; Martine Bail; Maria Johanna Rozendaal; Michel Bouvier; Pierre Thibault; James L Gleason; Sylvie Mader
Journal: Mol Cell Biol Date: 2012-07-23 Impact factor: 4.272

3. The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified.

Authors: Sofia Movérare-Skrtic; Anna E Börjesson; Helen H Farman; Klara Sjögren; Sara H Windahl; Marie K Lagerquist; Annica Andersson; Alexandra Stubelius; Hans Carlsten; Jan-Åke Gustafsson; Claes Ohlsson
Journal: Proc Natl Acad Sci U S A Date: 2014-01-06 Impact factor: 11.205

Review 4. The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer.

Authors: Cameron P Capper; James M Rae; Richard J Auchus
Journal: Horm Cancer Date: 2016-03-11 Impact factor: 3.869

5. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.

Authors: D K Biswas; L Averboukh; S Sheng; K Martin; D S Ewaniuk; T F Jawde; F Wang; A B Pardee
Journal: Mol Med Date: 1998-07 Impact factor: 6.354

6. Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36.

Authors: Lianguo Kang; Zhao-Yi Wang
Journal: J Cell Mol Med Date: 2009-10-15 Impact factor: 5.310

Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer.

1. Endocrine resistant breast cancer cells with loss of ERα expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage.

2. Role of SUMOylation in full antiestrogenicity.

3. The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified.

Review 4. The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer.

5. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.

6. Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36.

7. Isothiocyanates repress estrogen receptor alpha expression in breast cancer cells.

8. 17beta-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes.

Review 9. Role of ER-α36 in breast cancer by typical xenoestrogens.

Review 10. Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action.